Table 8.
Group | 0 week | 12-week | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean | ± | SE | n | Mean | ± | SE | ||||
Hematological Tests | WBC (/μL) | Placebo | 30 | 5197 | ± | 195 | 30 | 5137 | ± | 221 | |
Choline | 30 | 5187 | ± | 186 | 30 | 4917 | ± | 185 | |||
RBC (× 104/μL) | Placebo | 30 | 457 | ± | 7 | 30 | 456 | ± | 7 | ||
Choline | 30 | 458 | ± | 8 | 30 | 464 | ± | 8 | |||
Hemoglobin (g/dL) | Placebo | 30 | 14.2 | ± | 0.2 | 30 | 14.3 | ± | 0.2 | ||
Choline | 30 | 14.1 | ± | 0.3 | 30 | 14.3 | ± | 0.2 | |||
Hematocrit (%) | Placebo | 30 | 43.9 | ± | 0.6 | 30 | 44.6 | ± | 0.6 | ||
Choline | 30 | 43.6 | ± | 0.7 | 30 | 45.0 | ± | 0.7 | |||
Platelet Count (× 104/μL) | Placebo | 30 | 23.2 | ± | 1.0 | 30 | 23.6 | ± | 0.8 | ||
Choline | 30 | 24.8 | ± | 1.0 | 30 | 26.2 | ± | 1.0 | |||
MCV (fL) | Placebo | 30 | 96.2 | ± | 0.8 | 30 | 98.0 | ± | 0.7 | ||
Choline | 30 | 95.4 | ± | 0.7 | 30 | 97.2 | ± | 0.8 | |||
MCH (pg) | Placebo | 30 | 31.1 | ± | 0.3 | 30 | 31.4 | ± | 0.3 | ||
Choline | 30 | 30.7 | ± | 0.3 | 30 | 30.8 | ± | 0.2 | |||
MCHC (%) | Placebo | 30 | 32.3 | ± | 0.2 | 30 | 32.0 | ± | 0.2 | ||
Choline | 30 | 32.2 | ± | 0.1 | 30 | 31.7 | ± | 0.1 | |||
NEUT (%) | Placebo | 30 | 54.9 | ± | 1.4 | * | 30 | 56.3 | ± | 1.5 | |
Choline | 30 | 59.4 | ± | 1.4 | 30 | 58.5 | ± | 1.2 | |||
LYMPH (%) | Placebo | 30 | 36.2 | ± | 1.4 | * | 30 | 34.8 | ± | 1.3 | |
Choline | 30 | 31.8 | ± | 1.2 | 30 | 32.5 | ± | 1.0 | |||
MONO (%) | Placebo | 30 | 5.61 | ± | 0.14 | 30 | 5.76 | ± | 0.19 | ||
Choline | 30 | 5.51 | ± | 0.25 | 30 | 5.59 | ± | 0.28 | |||
EOSINO (%) | Placebo | 30 | 2.55 | ± | 0.33 | 30 | 2.43 | ± | 0.38 | ||
Choline | 30 | 2.61 | ± | 0.32 | 30 | 2.71 | ± | 0.28 | |||
BASO (%) | Placebo | 30 | 0.770 | ± | 0.078 | 30 | 0.730 | ± | 0.059 | ||
Choline | 30 | 0.693 | ± | 0.057 | 30 | 0.733 | ± | 0.056 | |||
Blood Biochemistry Tests | AST(GOT) (U/L) | Placebo | 30 | 22.1 | ± | 0.81 | 30 | 25.1 | ± | 1.51 | |
Choline | 30 | 21.8 | ± | 0.78 | 30 | 23.6 | ± | 1.00 | |||
ALT(GPT) (U/L) | Placebo | 30 | 19.6 | ± | 1.37 | 30 | 20.3 | ± | 1.38 | ||
Choline | 30 | 17.6 | ± | 1.33 | 30 | 18.3 | ± | 1.48 | |||
LD(LDH) (U/L) | Placebo | 30 | 202 | ± | 4 | 30 | 205 | ± | 5 | ||
Choline | 30 | 193 | ± | 4 | 30 | 204 | ± | 5 | |||
Total Bilirubin (mg/dL) | Placebo | 30 | 0.913 | ± | 0.052 | 30 | 0.877 | ± | 0.044 | ||
Choline | 30 | 0.890 | ± | 0.041 | 30 | 0.847 | ± | 0.046 | |||
ALP (U/L) | Placebo | 30 | 69.7 | ± | 3.1 | 30 | 71.0 | ± | 3.1 | ||
Choline | 30 | 76.3 | ± | 4.7 | 30 | 77.1 | ± | 4.2 | |||
γ-GT (γ-GTP) (U/L) | Placebo | 30 | 27.8 | ± | 2.9 | 30 | 26.6 | ± | 2.5 | ||
Choline | 30 | 24.6 | ± | 2.9 | 30 | 25.0 | ± | 3.4 | |||
Glucose (mg/dL) | Placebo | 30 | 91.7 | ± | 1.8 | 30 | 89.5 | ± | 1.4 | ||
Choline | 30 | 89.0 | ± | 1.7 | 30 | 89.8 | ± | 1.9 | |||
HbA1c (%) | Placebo | 30 | 5.49 | ± | 0.05 | 30 | 5.46 | ± | 0.06 | ||
Choline | 30 | 5.51 | ± | 0.04 | 30 | 5.48 | ± | 0.05 | |||
Total Cholesterol (mg/dL) | Placebo | 30 | 225 | ± | 6 | 30 | 228 | ± | 6 | ||
Choline | 30 | 222 | ± | 6 | 30 | 230 | ± | 6 | |||
LDL-Cholesterol (mg/dL) | Placebo | 30 | 132 | ± | 5 | 30 | 133 | ± | 5 | ||
Choline | 30 | 130 | ± | 6 | 30 | 133 | ± | 5 | |||
HDL-Cholesterol (mg/dL) | Placebo | 30 | 71.9 | ± | 4.1 | 30 | 78.5 | ± | 4.3 | ||
Choline | 30 | 69.5 | ± | 3.4 | 30 | 77.4 | ± | 4.1 | |||
Triglyceride (mg/dL) | Placebo | 30 | 107 | ± | 15 | 30 | 85.4 | ± | 10.0 | ||
Choline | 30 | 104 | ± | 12 | 30 | 102 | ± | 14 | |||
Phospholipid (mg/dL) | Placebo | 30 | 242 | ± | 6 | 30 | 243 | ± | 6 | ||
Choline | 30 | 241 | ± | 5 | 30 | 248 | ± | 6 | |||
Total Protein (g/dL) | Placebo | 30 | 7.35 | ± | 0.07 | 30 | 7.25 | ± | 0.08 | ||
Choline | 30 | 7.23 | ± | 0.07 | 30 | 7.22 | ± | 0.07 | |||
Albumin (g/dL) | Placebo | 30 | 4.39 | ± | 0.04 | 30 | 4.40 | ± | 0.04 | ||
Choline | 30 | 4.35 | ± | 0.05 | 30 | 4.39 | ± | 0.04 | |||
BUN (UN) (mg/dL) | Placebo | 30 | 15.8 | ± | 0.57 | 30 | 16.2 | ± | 0.76 | ||
Choline | 30 | 15.1 | ± | 0.70 | 30 | 16.1 | ± | 0.65 | |||
Creatinine (mg/dL) | Placebo | 30 | 0.847 | ± | 0.027 | 30 | 0.834 | ± | 0.028 | ||
Choline | 30 | 0.791 | ± | 0.025 | 30 | 0.781 | ± | 0.026 | |||
Uric Acid (mg/dL) | Placebo | 30 | 5.48 | ± | 0.21 | 30 | 5.42 | ± | 0.20 | ||
Choline | 30 | 5.55 | ± | 0.24 | 30 | 5.42 | ± | 0.23 | |||
Na (mEq/L) | Placebo | 30 | 141 | ± | 0 | 30 | 140 | ± | 0 | ||
Choline | 30 | 141 | ± | 0 | 30 | 141 | ± | 0 | |||
Cl (mEq/L) | Placebo | 30 | 103 | ± | 0 | 30 | 103 | ± | 0 | ||
Choline | 30 | 104 | ± | 0 | 30 | 103 | ± | 0 | |||
K (mEq/L) | Placebo | 30 | 4.25 | ± | 0.06 | 30 | 4.18 | ± | 0.05 | ||
Choline | 30 | 4.21 | ± | 0.05 | 30 | 4.27 | ± | 0.05 | |||
Ca (mg/dL) | Placebo | 30 | 9.47 | ± | 0.06 | 30 | 9.32 | ± | 0.04 | ||
Choline | 30 | 9.48 | ± | 0.05 | 30 | 9.40 | ± | 0.05 | |||
Urinalysis | Acidity (pH) | Placebo | 30 | 6.30 | ± | 0.14 | 30 | 6.27 | ± | 0.13 | |
Choline | 30 | 6.10 | ± | 0.12 | 30 | 6.15 | ± | 0.14 | |||
Specific Gravity | Placebo | 30 | 1.01 | ± | 0.00 | 30 | 1.02 | ± | 0.00 | ||
Choline | 30 | 1.02 | ± | 0.00 | 30 | 1.02 | ± | 0.00 |
Mean ± SE of 30 subject
*statistical significance by Student’s t-test for between-group at P < 0.05
†statistical significance by Paired t-test for within-group at P < 0.05